CD44 and neoplasm: In research, CD44+CD24 BCSCs with significant tumorigenic potential were found using serum-free suspension culture thanks to their elevated expression of tumor stem cell markers such ALDH1A1, C-Myc, OCT4, NANOG, KLF 4, and SOX2.